How genetic testing helped Briella find answers and hope
Discover how Briella’s story highlights the impact of pharmacogenomic testing in personalizing treatments and transforming patient care.
Discover how Briella’s story highlights the impact of pharmacogenomic testing in personalizing treatments and transforming patient care.
David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was
The pharmacogenomics program at Children’s Minnesota utilizes molecular testing to analyze genes in order to understand how a patient will metabolize medications.
Learn more about the Children’s Minnesota pharmacogenomics program and how it helps find safer medications for patients.
A day for our generous community to join together to ensure that even the tiniest hearts get the strongest possible start.